Collections:
Other Resources:
DOI: 10.1182/blood.2021014689
Paper Summary:
Title: Asciminib: new therapeutic option in chronic phase CML with treatment failure.
Author(s): Yeung, David T; Shanmuganathan, Naranie; Hughes, Timothy P
Year: 2022
DOI: 10.1182/blood.2021014689
URL: https://doi.org/10.1182/blood.2021014689
Received on: 2022-10-26
✍: FYIcenter.com
2022-10-26, ∼1371👍, 0💬
Related Topics:
Popular Posts:
Paper Summary: DOI: 10.1016/j.matpr.2023.04. 366Received on: 2024-04-29
Paper Summary: Title: When do B2B brands influence the decision making of organizational buyers? An ...
Paper Summary: DOI: 10.1080/07853890.2024.23 07502Received on: 2024-02-01
Paper Summary: DOI: 10.3390/molecules2719654 8Received on: 2024-05-26
Paper Summary: Title: Intimate Relations: Exploring Indian Sexuality. SUDHIR KAKAR Author(s): OWEN M...
